• Je něco špatně v tomto záznamu ?

Possible effect of OAS1 and TMPRSS6 but not DPP4 and ZNF335 polymorphisms on COVID-19 severity in the Czech population

JA. Hubáček, T. Philipp, V. Adámková, O. Májek, D. Dlouhá, L. Dušek

. 2023 ; 31 (4) : 235-239. [pub] -

Jazyk angličtina Země Česko

Typ dokumentu časopisecké články

Perzistentní odkaz   https://www.medvik.cz/link/bmc24002924

Digitální knihovna NLK
Zdroj

E-zdroje Online Plný text

NLK Free Medical Journals od 2004
ProQuest Central od 2009-03-01 do Před 6 měsíci
Medline Complete (EBSCOhost) od 2006-03-01 do Před 6 měsíci
Nursing & Allied Health Database (ProQuest) od 2009-03-01 do Před 6 měsíci
Health & Medicine (ProQuest) od 2009-03-01 do Před 6 měsíci
Public Health Database (ProQuest) od 2009-03-01 do Před 6 měsíci
ROAD: Directory of Open Access Scholarly Resources od 1993

Odkazy

PubMed 38309700
DOI 10.21101/cejph.a7906
Knihovny.cz E-zdroje

OBJECTIVES: The acute respiratory syndrome, known as COVID-19, is characterised by high morbidity and increased mortality. Genetic factors may partially explain the differences in susceptibility to and severity of COVID-19. METHODS: We have analysed common functional polymorphisms within the OAS1 (rs4767027), TMPRSS6 (rs855791), DPP4 (rs3788979), and ZNF335 (rs3848719) genes in SARS-CoV-2 positive subjects (n = 521, different disease severity) and in population controls (n = 2,559 subjects, COVID-19 status unknown). RESULTS: Neither DPP4 nor ZNF335 were associated with disease susceptibility or severity in the Czech population in any of the models used for calculation. T allele carriers of the OAS1 polymorphism seem to be protective against symptomatic COVID-19 (p = 0.002 calculated for trend; asymptomatic, symptomatic, hospitalised). Similarly, within the TMPRSS6, minor TT homozygotes associated with lower plasma Fe concentrations were underrepresented in the overall patient group (p = 0.044; OR = 0.77, 95% CI: 0.59-0.99), and the difference was mainly driven by the severe COVID-19 subjects. In general, risky homozygotes of these two polymorphisms were less frequent than expected in the group of hospitalised COVID-19 survivors. CONCLUSIONS: Common variants within OAS1 (rs4767027) and TMPRSS6 (rs855791) play some role in COVID-19 pathology in the Czech Caucasian population. Whether the depletion of minor allele carriers of these two variants is associated with increased COVID-19 mortality, needs to be analysed in an external confirmatory study.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc24002924
003      
CZ-PrNML
005      
20250312094529.0
007      
ta
008      
240215s2023 xr f 000 0|eng||
009      
AR
024    7_
$a 10.21101/cejph.a7906 $2 doi
035    __
$a (PubMed)38309700
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a xr
100    1_
$a Hubáček, Jaroslav, $d 1966- $u Experimental Medicine Centre, Institute for Clinical and Experimental Medicine, Prague, Czech Republic $u Department of Endocrinology and Metabolism, Third Department of Internal Medicine, First Faculty of Medicine, Charles University and General University Hospital, Prague, Czech Republic $7 nlk20050169367
245    10
$a Possible effect of OAS1 and TMPRSS6 but not DPP4 and ZNF335 polymorphisms on COVID-19 severity in the Czech population / $c JA. Hubáček, T. Philipp, V. Adámková, O. Májek, D. Dlouhá, L. Dušek
520    9_
$a OBJECTIVES: The acute respiratory syndrome, known as COVID-19, is characterised by high morbidity and increased mortality. Genetic factors may partially explain the differences in susceptibility to and severity of COVID-19. METHODS: We have analysed common functional polymorphisms within the OAS1 (rs4767027), TMPRSS6 (rs855791), DPP4 (rs3788979), and ZNF335 (rs3848719) genes in SARS-CoV-2 positive subjects (n = 521, different disease severity) and in population controls (n = 2,559 subjects, COVID-19 status unknown). RESULTS: Neither DPP4 nor ZNF335 were associated with disease susceptibility or severity in the Czech population in any of the models used for calculation. T allele carriers of the OAS1 polymorphism seem to be protective against symptomatic COVID-19 (p = 0.002 calculated for trend; asymptomatic, symptomatic, hospitalised). Similarly, within the TMPRSS6, minor TT homozygotes associated with lower plasma Fe concentrations were underrepresented in the overall patient group (p = 0.044; OR = 0.77, 95% CI: 0.59-0.99), and the difference was mainly driven by the severe COVID-19 subjects. In general, risky homozygotes of these two polymorphisms were less frequent than expected in the group of hospitalised COVID-19 survivors. CONCLUSIONS: Common variants within OAS1 (rs4767027) and TMPRSS6 (rs855791) play some role in COVID-19 pathology in the Czech Caucasian population. Whether the depletion of minor allele carriers of these two variants is associated with increased COVID-19 mortality, needs to be analysed in an external confirmatory study.
650    _2
$a lidé $7 D006801
650    _2
$a 2',5'-oligoadenylátsynthetasa $7 D015088
650    12
$a COVID-19 $x genetika $7 D000086382
650    _2
$a dipeptidylpeptidasa 4 $7 D018819
650    _2
$a DNA vazebné proteiny $7 D004268
650    _2
$a membránové proteiny $7 D008565
650    _2
$a jednonukleotidový polymorfismus $7 D020641
650    _2
$a SARS-CoV-2 $7 D000086402
650    _2
$a serinové endopeptidasy $x genetika $7 D012697
650    _2
$a transkripční faktory $7 D014157
651    _2
$a Česká republika $x epidemiologie $7 D018153
655    _2
$a časopisecké články $7 D016428
700    1_
$a Philipp, Tom, $d 1968- $u Clinic of Rheumatology and Physiotherapy, Third Faculty of Medicine, Charles University and Thomayer University Hospital, Prague, Czech Republic $7 jn20000401983
700    1_
$a Adámková, Věra, $d 1954- $u Department of Preventive Cardiology, Institute for Clinical and Experimental Medicine, Prague, Czech Republic $7 jx20050329003
700    1_
$a Májek, Ondřej, $d 1985- $u Institute of Health Information and Statistics of the Czech Republic, Prague, Czech Republic $u Institute of Biostatistics and Analyses, Faculty of Medicine, Masaryk University, Brno, Czech Republic $7 xx0156444
700    1_
$a Dlouhá, Dana $u Experimental Medicine Centre, Institute for Clinical and Experimental Medicine, Prague, Czech Republic $7 xx0204810
700    1_
$a Dušek, Ladislav, $d 1967- $u Institute of Health Information and Statistics of the Czech Republic, Prague, Czech Republic $u Institute of Biostatistics and Analyses, Faculty of Medicine, Masaryk University, Brno, Czech Republic $7 mzk2003181727
773    0_
$w MED00001083 $t Central European journal of public health $x 1210-7778 $g Roč. 31, č. 4 (2023), s. 235-239
856    41
$u https://pubmed.ncbi.nlm.nih.gov/38309700 $y Pubmed
910    __
$a ABA008 $b B 1829 $c 562 $y p $z 0
990    __
$a 20240215 $b ABA008
991    __
$a 20250312094536 $b ABA008
999    __
$a ok $b bmc $g 2283460 $s 1212660
BAS    __
$a 3
BAS    __
$a PreBMC-MEDLINE
BMC    __
$a 2023 $b 31 $c 4 $d 235-239 $e - $i 1210-7778 $m Central European journal of public health $n Cent Eur J Public Health $x MED00001083
LZP    __
$b NLK124 $a Pubmed-20240215
Zpět

Najít záznam

Citační ukazatele

Možnosti archivace